Study identified correlates of protection healthy individuals who have received three doses of Pfizer- BNT162b2 vaccine.
House panel advances bills targeting rare disease, priority review vouchers
WASHINGTON — Lawmakers advanced the reauthorization of an FDA program designed to stimulate the development of treatments for pediatric rare diseases, despite some opposition from